Challenges and Solutions in Animal Production
OIE Headquarters, Paris, France
December 12-15, 2016
Program Review - Objectives and Expected Outcomes
Cyril G. Gay
Prioritization of diseases for which vaccines could reduceantimicrobial use in animals
Elisabeth Erlacher-Vindel
Challenges and solutions for improved intestinal vaccinations
Eric Cox
Recombinant orally effective vaccine platforms expressingputative conserved antigens for reduced antimicrobial usage inpoultry
Lisa R. Bielke
Pasteurellaceae oral vaccine vector for economically importantdiseases of cattle
Robert Briggs
Exploiting CRISPR-Cas nucleases to produce sequence-specificantimicrobials
David Bikard
Novel antimicrobial compounds from microbial sources
Joseph O. Rich
Bacteriocins as alternatives to antibiotics: the case of enterocinsDD14 and DD28
Djamel Drider
Artilysins - Novel antibacterial tools for industrial animal proteinproduction
Stefan Miller
Microbial-ecology guided discovery of antibiofilm compoundsfrom marine sponges
Jason Kwan
Phytonutrients as alternative feeding strategy to improve performance of cattle without using an antibiotic
Sergio Calsamiglia
Impact of dietary tannins on rumen microbiota in bovine
Mariano E. Fernández Miyakawa
Meta-analysis of broiler research shows that VariumTM results infeed efficiency equal to antibiotics
Fang Chi
Innate defense mechanisms and passive immunity
Peter M. Heegaard
Immunomodulators derived from host defense peptides
Albert van Dijk
Egg shell membrane improves immunity of post hatch poultry: aparadigm for nutritional immunomodulation
Narayan C. Rath
Green algal sulfated polysaccharides: a natural alternative toantibiotics via modulation of the intestinal immune response
Mustapha Berri
Maintenance of vascular integrity via ARF6-GTP inhibitionprotects mice from MDR Acinetobacter infection
Ashraf S. Ibrahim
Non-resistance-inducing antibacterial polymers andnanomedicines
Song Liu
Bacterial anti-virulence strategy as an alternative to antibiotics
Damien Maura
EU approach to authorization of novel technologies withparticular emphasis on alternatives to antibiotics
Faye Ioannou
FDA’s innovation initiative to evaluate novel emergingtechnologies and international cooperation in the area ofinnovation
Cindy Burnsteel
Regulation on the use of antibiotics and authorization of herbalmedicines in China
Shixin Xu
Do innovative solutionsrequire novel regulatory paradigms?
Patricia Logie
The sequence of success: antibiotic alternative development fromthe startup perspective
Lucia Mokres